Despite of recent advances in our understanding of the immune regulatory role of GLP-1/GLP-1R, there are many challenges to overcome in this area
By contrast, D-lactate, though present in trace amounts from bacterial metabolism and certain metabolic disorders, has not yet been systematically investigated in ferroptosis contexts
However, the magnitude of these effects is typically modest at the starting dose and becomes more pronounced as the dose is gradually increased over subsequent weeks
Use the no-two-late-nights rule
Common side effects include: Weight gain Nausea or vomiting Diarrhea Asthma or breathing problems Hair whitening or loss Skin rashes Hives or allergic reactions Rare severe reactions like toxic epidermal necrolysis or Steven-Johnson syndrome (with higher doses) Always consult with a qualified practitioner to minimize the risk of side effects
Conclusion: The cardioprotective effects and low risk of hypoglycemia of GLP-1 RAs make them preferred agents in any multidisciplinary approach aiming to reduce CV disease burden and improve prognosis
